ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. H-1. がん進展制御研究所
  2. h-1 10. 学術雑誌掲載論文
  3. 1. 査読済論文

Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma

https://doi.org/10.24517/00061539
https://doi.org/10.24517/00061539
7f4f1432-764e-4440-bf3f-98f190f0de7b
名前 / ファイル ライセンス アクション
CA-PR-MUKAIDA-N-24-1839.pdf CA-PR-MUKAIDA-N-1839.pdf (1.5 MB)
license.icon
Item type 学術雑誌論文 / Journal Article(1)
公開日 2021-03-26
タイトル
タイトル Emergence of immunotherapy as a novel way to treat hepatocellular carcinoma
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
ID登録
ID登録 10.24517/00061539
ID登録タイプ JaLC
著者 Mukaida, Naofumi

× Mukaida, Naofumi

WEKO 85791
e-Rad 30182067
金沢大学研究者情報 30182067
研究者番号 30182067

Mukaida, Naofumi

Search repository
Nakamoto, Yasunari

× Nakamoto, Yasunari

WEKO 91854
e-Rad 40293352

Nakamoto, Yasunari

Search repository
著者別表示 向田, 直史

× 向田, 直史

向田, 直史

Search repository
中本, 安成

× 中本, 安成

中本, 安成

Search repository
提供者所属
内容記述タイプ Other
内容記述 金沢大学がん進展制御研究所
書誌情報 World Journal of Gastroenterology

巻 24, 号 17, p. 1839-1858, 発行日 2018-05-07
ISSN
収録物識別子タイプ ISSN
収録物識別子 1007-9327
NCID
収録物識別子タイプ NCID
収録物識別子 AA12048247
DOI
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 10.3748/wjg.v24.i17.1839
出版者
出版者 W J G Press / Baishideng Publishing Group Co
抄録
内容記述タイプ Abstract
内容記述 Tumor immunity proceeds through multiple processes, which consist of antigen presentation by antigen presenting cells (APCs) to educate effector cells and destruction by the effector cytotoxic cells. However, tumor immunity is frequently repressed at tumor sites. Malignantly transformed cells rarely survive the attack by the immune system, but cells that do survive change their phenotypes to reduce their immunogenicity. The resultant cells evade the attack by the immune system and form clinically discernible tumors. Tumor microenvironments simultaneously contain a wide variety of immune suppressive molecules and cells to dampen tumor immunity. Moreover, the liver microenvironment exhibits immune tolerance to reduce aberrant immune responses to massively-exposed antigens via the portal vein, and immune dysfunction is frequently associated with liver cirrhosis, which is widespread in hepatocellular carcinoma (HCC) patients. Immune therapy aims to reduce tumor burden, but it is also expected to prevent non-cancerous liver lesions from progressing to HCC, because HCC develops or recurs from noncancerous liver lesions with chronic inflammatory states and/or cirrhosis and these lesions cannot be cured and/or eradicated by local and/or systemic therapies. Nevertheless, cancer immune therapy should augment specific tumor immunity by using two distinct measures: enhancing the effector cell functions such as antigen presentation capacity of APCs and tumor cell killing capacity of cytotoxic cells, and reactivating the immune system in immune-suppressive tumor microenvironments. Here, we will summarize the current status and discuss the future perspective on immune therapy for HCC. © The Author(s) 2018.
内容記述
内容記述タイプ Other
内容記述 Supported by (in part) Research Programs on the Innovative Development and Application for New Drugs for Hepatitis B (No. 17fk0310116h0001) from the Japan Agency for Medical Research and Development (AMED) and Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University.
権利
権利情報 Copyright © 2018 Authors.
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
関連URI
識別子タイプ URI
関連識別子 https://www.wjgnet.com/1007-9327/full/v24/i17/1839.htm
関連名称 https://www.wjgnet.com/1007-9327/full/v24/i17/1839.htm
関連URI
識別子タイプ URI
関連識別子 https://www.wjgnet.com/1007-9327/index.htm
関連名称 https://www.wjgnet.com/1007-9327/index.htm
戻る
0
views
See details
Views

Versions

Ver.1 2023-07-27 15:15:46.522524
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3